CENTREVILLE, Va., June 16, 2022 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) was selected by the U.S. Defense Health Agency (DHA) to provide health-related research and development and additional activities of interest for the Department of Defense and the Military Healthcare System. The $10 billion ceiling value Omnibus IV is a five-year multiple-award indefinite delivery/indefinite quantity contract with one five-year option period.
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.